Superoxide Activates Ferroptosis via the Haber-Weiss Reaction and Enhances Age-Related Macular Degeneration

Area of Science:

• Biochemistry
• Cell Biology
• Ophthalmology

Background:

• Antioxidant decline is a key factor in age-related macular degeneration (AMD).
• Ferroptosis, an iron-dependent cell death, is linked to chronic degenerative diseases.
• Superoxide's role in ferroptosis within retinal pigment epithelium (RPE) cells and its contribution to dry AMD require further elucidation.

Purpose of the Study:

• To investigate the role of superoxide in ferroptosis of RPE cells.
• To explore the underlying mechanisms of superoxide-induced ferroptosis in dry AMD.
• To evaluate potential therapeutic strategies targeting superoxide-activated ferroptosis for dry AMD prevention.

Main Methods:

• Silencing of manganese superoxide dismutase (MnSOD/SOD2) in RPE cells.
• Induction of ferroptosis using blue light exposure to increase superoxide anions.
• Assessment of GPX4 degradation and ferroptosis markers.
• Validation in Sod2^+/- mice models exhibiting dry AMD phenotypes.
• Testing of SOD mimetics, iron chelators, and GPX4 overexpression as interventions.

Main Results:

• Superoxide activates ferroptosis in RPE cells via the Haber-Weiss reaction, contributing to dry AMD.
• MnSOD deficiency exacerbates ferroptosis by promoting GPX4 degradation.
• Blue light-induced ferroptosis in RPE is a validated driver of dry AMD in mice.
• SOD mimetics effectively protect RPE cells from phototoxicity by reducing ferroptosis.
• Iron chelation or GPX4 overexpression significantly inhibits ferroptosis.

Conclusions:

• Excessive superoxide promotes phospholipid peroxidation and RPE cell ferroptosis, driving dry AMD.
• Elevating MnSOD levels can inhibit RPE cell ferroptosis, offering a promising preventive strategy for dry AMD.
• Targeting superoxide-activated ferroptosis presents a novel therapeutic avenue for managing dry AMD.